Brian Kane

Spero Therapeutics, Inc.

NIH Rank #2087
  • Early Career

NIH Funding · FY2024

Total Funding
$3.4M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#2,087
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3.4M across 1 grant · National rank #2087.

Top grants by award amount

Brian Kane's NIH grant portfolio, ranked by award amount.

  • 75N93021C00022-P00012-9999-1N01
    Development of Therapeutic Products for Biodefense, AntiMicrobial Resistant (AMR) Infections and Emerging Infectious Diseases
    $3.4M
    award amount

Affiliation

Institutions that have administered grants for Brian Kane.

Affiliated with Spero Therapeutics, Inc. (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Spero Therapeutics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2087
  6. 2024
    Entered Top 25% Nationally
    Ranked #2087